United States
Print page content Print
Increase text size Decrease text size
Text Size
CYTOPOINT - now approved for the treatment of allergic dermatitis! Learn more

Conduct food trial

Conduct food trial

In food allergy trials, APOQUEL controls itch,
protects the bond and improves compliance1,2 Apoquel

Continue APOQUEL and conduct a food allergy trial

  • Owners may resist even considering a dietary trial if relief is not offered during the process
  • Committing to keeping dogs comfortable helps gain support and compliance from the pet owners
  • The pharmacokinetics of APOQUEL allow quick, reliable assessment of a diet trial within 24-48 hours after discontinuation of APOQUEL
    • Easily turn on and turn off allergic itch control as necessary

Relieve itch with APOQUEL during an 8-week dietary trial3


Conduct dietary allergy trial with APOQUEL

TAILOR YOUR APPROACH WITH INDIVIDUALIZED CARE

CYTOPOINT is a great option for allergic itch relief when treats are not allowed (to hide oral medication) during a food trial

Learn more at APOQUEL.COM

APOQUEL Indications: Control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

APOQUEL IMPORTANT SAFETY INFORMATION: Do not use APOQUEL in dogs less than 12 months of age or those with serious infections. APOQUEL may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse. APOQUEL has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporine. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. APOQUEL has been used safely with many common medications including parasiticides, antibiotics and vaccines.

For more information, please see the full Prescribing Information.

CYTOPOINT Indications: CYTOPOINT has been shown to be effective for the treatment of dogs against allergic dermatitis and atopic dermatitis.

References: 1. Cosgrove SB, Cleaver DM, King VL, et al. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. Vet Dermatol. 2015;26(3):171-179. doi:10.1111/vde.12194. 2. McKay L. Making a difference for dogs with atopic dermatitis: when to use Apoquel and when to use Cytopoint. dvm360. July 13, 2017. http://veterinarynews.dvm360.com/making-difference-dogs-with-atopic-dermatitis-when-use-apoquel-and-when-use-cytopoint. Accessed February 2, 2018. 3. Olivry T, Mueller R, Prelaud P, et al. Critically appraised topic on adverse food reactions of companion animals (1): duration of elimination diets. BMC Vet Res. 2015;11:225. doi:10.1186/s12917-015-0541-3. 

The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
© 2019 Zoetis Services LLC. All rights reserved ZPC-00064R1